PhRMA's Scott LaGanga discusses the expanding influence of state policymaking on drug pricing, PBM reform, and efforts to translate policy changes into lower out-of-pocket costs for patients.
|Articles|February 20, 2013
Highlights from iPharma 2013: Tweet Roundup
Author(s)Clark Herman
CBI’s 12th Annual Digital Innovation Forum, better known as iPharma, covered a broad range of topics from maintaining salient SEO strategy to effectively managing digital project pipelines across different departments.
Advertisement
CBI’s 12th Annual Digital Innovation Forum, better known as iPharma, covered a broad range of topics from maintaining salient SEO strategy to effectively managing digital project pipelines across different departments. Watch the video below for some of the conversation around the presentations, or to read a more in-depth account, click
Advertisement
Related to this article
FDA grants accelerated approval to INOVIO’s Voceryq for reducing surgery frequency in adults with recurrent respiratory papillomatosis.
Dr. Jay Lalezari, CytoDyn’s CEO and CMO, discusses his path from HIV clinician to drug developer.
Sun Pharma's IL-23 inhibitor tildrakizumab gains a psoriatic arthritis indication; the announcement cited no phase 3 efficacy figures.
Brox.AI's co-founder and CEO on why telling an AI to pretend to be a doctor isn’t the same as cloning one — and why that distinction matters for pharma.
Shionogi’s Dr. Draica on why mild COVID-19 still matters, how XOCOVA blocks replication before symptoms, and why prevention beats treatment.
Earlier pediatric planning, innovative trial design, and closer collaboration among regulators, industry, and families are needed to close the persistent gap between the evidence available for adult and pediatric treatments.
BioMarin licenses long-acting Fabry enzyme replacement therapy HM15421/GC1134A, while Ferring agrees to acquire fertility biotech Gameto.
Advertisement
Advertisement
Trending on PharmExec
1
What is it Like to Go From Treating Patients Directly to Running a Company?
2
FDA Grants Accelerated Approval to INOVIO’s Voceryq for RRP, Reducing Surgical Burden
3
FDA Approves Ilumya for Adults With Active Psoriatic Arthritis
4
States Take Center Stage in the Drug Pricing Fight
5